Irschik Herbert, Schummer Dietmar, Höfle Gerhard, Reichenbach Hans, Steinmetz Heinrich, Jansen Rolf
Research Group Microbial Drugs, Helmholtz Centre for Infection Research (HZI), Inhoffenstrasse 7, 38124 Braunschweig, Germany.
J Nat Prod. 2007 Jun;70(6):1060-3. doi: 10.1021/np070115h. Epub 2007 Jun 5.
Etnangien (1), a new macrolide antibiotic active against Gram-positive bacteria, was isolated from the culture broth of the myxobacterium Sorangium cellulosum, strains So ce750 and So ce1045. Spectroscopic structure elucidation of 1 revealed a complex macrocyclic lactone bearing a modified C21 carboxylic acid side chain. The latter contains two allylic hydroxyl groups and an all-E hexaene unit, which provides the characteristic UV chromophore of 1. Initial studies toward the mechanism of action showed that bacterial and viral nucleic acid polymerases are inhibited by etnangien (1).
埃坦吉恩(1)是一种对革兰氏阳性菌有活性的新型大环内酯类抗生素,从粘细菌纤维素堆囊菌So ce750和So ce1045菌株的培养液中分离得到。对1的光谱结构解析表明其为一种带有修饰的C21羧酸侧链的复杂大环内酯。该侧链含有两个烯丙基羟基和一个全-E型己烯单元,这构成了1的特征紫外发色团。对其作用机制的初步研究表明,细菌和病毒核酸聚合酶会受到埃坦吉恩(1)的抑制。